Description of the study population
| Description of the study population . | ESI 2, n = 23 . | ESI 3, n = 43 . | P value . |
|---|---|---|---|
| Age, median (range), y | 31 (22-77) | 31 (22-74) | .788 |
| Gender, % | .12 | ||
| Male | 52.2 | 32.6 | |
| Female | 47.8 | 67.4 | |
| SCD Genotype, % | .339 | ||
| HbSS | 69.6 | 62.8 | |
| HbSC | 4.3 | 16.3 | |
| HbS-β0 thalassemia | 4.3 | 9.3 | |
| HbS-β+ thalassemia | 21.7 | 11.6 | |
| Pain score at triage, median (range) | 9 (6-10) | 9 (6-10) | .567 |
| Description of the study population . | ESI 2, n = 23 . | ESI 3, n = 43 . | P value . |
|---|---|---|---|
| Age, median (range), y | 31 (22-77) | 31 (22-74) | .788 |
| Gender, % | .12 | ||
| Male | 52.2 | 32.6 | |
| Female | 47.8 | 67.4 | |
| SCD Genotype, % | .339 | ||
| HbSS | 69.6 | 62.8 | |
| HbSC | 4.3 | 16.3 | |
| HbS-β0 thalassemia | 4.3 | 9.3 | |
| HbS-β+ thalassemia | 21.7 | 11.6 | |
| Pain score at triage, median (range) | 9 (6-10) | 9 (6-10) | .567 |
HbSS, Hemoglobin SS; HbSC, Hemoglobin SC; HbS, Hemoglobin S.